Qiagen secures FDA approval to extend EGFR test use in lung cancer

02:41 EDT 2 Oct 2018 | Compelo Medical Devices

The therascreen EGFR RGQ PCR kit can now be used as a companion diagnostic to guide the use of three FDA-approved therapies, including also GILOTRIF (Afatinib) from Boehringer

The post Qiagen secures FDA approval to extend EGFR test use in lung cancer appeared first on Compelo Medical Devices.

Original Article: Qiagen secures FDA approval to extend EGFR test use in lung cancer

More From BioPortfolio on "Qiagen secures FDA approval to extend EGFR test use in lung cancer"